Goodbody Health Inc. - Move up to OTCQB from OTC pink market
RNS Number : 3258C
Goodbody Health Inc.
22 February 2022

22 February 2022

Goodbody Health Inc.
("Goodbody Health", or the "Company")

Move up to OTCQB from OTC pink market


Goodbody Health Inc. (GDBYF) is pleased to announce that it has moved up a tier from the over the counter market ("OTC") pink market to the OTCQB market. Goodbody Health welcomes the increased compliance and scrutiny, demonstrating the strong governance of the group and allowing it to be more visible to larger investors.

As a verified market with efficient access to U.S. investors, OTCQB helps companies build shareholder value with a goal of enhancing liquidity and achieving fair valuation. It gives companies the flexibility to control reporting costs and complexity, while still providing investors with a premium market for their securities. The OTCQB platform enables companies to provide current public information that investors need to analyze, value and trade a security, with convenient trading through an investors preferred broker or financial advisor, transparent pricing with real-time quotes, and trusted disclosure.

Geremy Thomas, Executive Chairman, said; "This move to a higher tier of the OTC demonstrates our ability and wish to be part of a regulated but flexible market to offer the best environment for our US investor base."


For further information:

Marc Howells

Chief Executive Officer

Goodbody Health Inc.

+44 (0) 20 7971 1255

Anne Tew

Chief Financial Officer

Goodbody Health Inc.

+44 (0) 20 7971 1255



AQSE Corporate Adviser

Arden Partners plc

Antonio Bossi / George Morgan

+ 44 (0) 20 7614 5900 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.